![David Winter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Winter
Amministratore Delegato presso TriMed Research, Inc.
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Jean-Jacques Bienaimé | M | 70 |
SangStat Medical Corp.
| 4 anni |
Paul Okimoto | M | 88 |
Human BioSystems, Inc.
![]() Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 11 anni |
George Tsukuda | M | - |
Human BioSystems, Inc.
![]() Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Larry McCleary | M | 73 |
Human BioSystems, Inc.
![]() Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 4 anni |
Claude Miller | M | 73 |
SangStat Medical Corp.
| 3 anni |
Robert E. Strom | M | - |
Human BioSystems, Inc.
![]() Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Luis H. Toledo-Pereyra | M | 79 |
Human BioSystems, Inc.
![]() Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 9 anni |
Rachmat M. Umar | M | - |
Human BioSystems, Inc.
![]() Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Carole Nüchterlein | F | 62 |
SangStat Medical Corp.
| 3 anni |
Frank J. Drechsler | M | 57 |
Human BioSystems, Inc.
![]() Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 10 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- David Winter
- Contatti personali